Brief: Vicore Pharma Holding Q3 Operating Loss Widens To SEK 22.8 Mln
Nov 8 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* INTERIM REPORT JANUARY-SEPTEMBER 2019
* Q3 OPERATING LOSS WAS -22.8 MSEK (-11.2)
* Q3 OPERATING INCOME AMOUNTED TO 0.0 MSEK (0.1)
Source text for Eikon: ID:nWkr1Y8P6m
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2